CONSEQUÊNCIAS E TRATAMENTO DA SÍNDROME METABÓLICA NA POPULAÇÃO IDOSA

Leyce de Paiva Alves; Izaias Souza Barros Netto; Násser Cavalcante Hijazi; Victória Christine de Almeida Santos; Blandina Luanni Lima e Silva; Mirlen Alves da Costa Verzeletti; Gelma Maria Jerônymo Vieira Neves; Ricardo Shinji Takahashi; Victor Olavo da Silva; Cleber Queiroz  Leite

doi:10.51891/rease.v9i12.11994

Authors

Leyce de Paiva Alves Centro Universitário São Lucas - UNISL https://orcid.org/0009-0007-7123-1200
Izaias Souza Barros Netto Centro Universitário São Lucas - UNISL https://orcid.org/0000-0003-4377-6397
Násser Cavalcante Hijazi Centro Universitário São Lucas - UNISL https://orcid.org/0009-0000-6920-7446
Victória Christine de Almeida Santos Universidade Estadual de Ciências da Saúde de Alagoas - UNCISAL https://orcid.org/0000-0002-2229-3508
Blandina Luanni Lima e Silva Centro Universitário São Lucas - UNISL https://orcid.org/0009-0001-9028-0055
Mirlen Alves da Costa Verzeletti Centro Universitário São Lucas - UNISL https://orcid.org/0009-0000-1494-7631
Gelma Maria Jerônymo Vieira Neves Centro Universitário São Lucas - UNISL https://orcid.org/0009-0005-9326-8122
Ricardo Shinji Takahashi Centro Universitário São Lucas - UNISL https://orcid.org/0009-0002-1963-4364
Victor Olavo da Silva Centro Universitário São Lucas - UNISL https://orcid.org/0009-0004-9648-291X
Cleber Queiroz Leite Faculdade de Ensino Superior da Amazônia Reunida - FESAR https://orcid.org/0000-0002-7847-1166

DOI:

https://doi.org/10.51891/rease.v9i12.11994

Keywords:

Polypharmacy. Elderly Health. Metabolic syndrome.

Abstract

OBJECTIVE: To highlight the main consequences and factors that influence the prognosis of metabolic syndrome in the elderly. METHODOLOGY: This research is an integrative literature review. RESULT AND DISCUSSION: The global aging process contributes to the increase in chronic diseases in the elderly population. Metabolic syndrome, as it is a multifactorial disease, requires treatment of the underlying pathologies associated with changes in lifestyle. Furthermore, care is needed to avoid polypharmacy in elderly patients, considering that drug interactions can worsen their condition. Therefore, good guidance from the multidisciplinary team is necessary when indicating a course of action for elderly patients with MS, so that they can use the prescribed treatment and avoid complications due to the pathology. FINAL CONSIDERATIONS: The study made it possible to identify that the main consequences of MS in the elderly are the increased risk of cardiovascular diseases, drug interactions and morbidity and mortality. Therefore, it is essential to guide the patient to undergo appropriate treatment with lifestyle changes for a better prognosis and well-being.